Metabolic Therapy for Cancer via Ketogenic Diet and Hyperbaric Oxygen
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current cancer treatments, such as surgery, chemotherapy, and radiation, are ineffective against metastatic cancer and often cause toxic side effects, while conventional therapies fail to address the underlying energy metabolism abnormalities in cancer cells, leading to limited survival outcomes for patients with late-stage cancer.
Innovation Solution
A ketogenic diet supplemented with ketones, combined with hyperbaric oxygen therapy, targets cancer cells by restricting glucose availability and enhancing oxidative stress, thereby inhibiting cancer cell growth and metastasis.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional cancer treatments (surgery, chemotherapy, radiation) are used, then primary tumors can be controlled, but metastatic disease progresses and toxic side effects occur
Solution Approach 1:
The invention changes the metabolic parameters of cancer cells by inducing ketosis through ketogenic diet and supplementing with ketone bodies (beta-hydroxybutyrate and acetoacetate). This metabolic parameter change shifts cancer cells from glycolytic to oxidative metabolism, creating a therapeutic effect that controls tumor growth without the toxic side effects of conventional treatments.
Solution Approach 2:
The invention converts the harmful effect of metabolic abnormality in cancer cells (Warburg effect - preferential use of glycolysis) into a benefit by exploiting this metabolic vulnerability. By providing ketone bodies and restricting glucose, the treatment starves cancer cells of their preferred energy source while forcing them into an inefficient metabolic state, thereby converting their metabolic defect into a therapeutic opportunity.
2Reliability
If conventional therapies are applied, then some primary tumors are controlled, but survival outcomes for late-stage metastatic cancer remain poor
Solution Approach 1:
The invention performs preliminary action by fundamentally altering the metabolic landscape before cancer cells can progress or resist treatment. By establishing ketosis and providing ketone bodies upfront, the treatment creates a metabolic environment that is hostile to cancer cell survival and proliferation, preventing rather than just responding to disease progression.
Solution Approach 2:
The invention introduces ketone bodies (beta-hydroxybutyrate and acetoacetate) as intermediary substances that mediate the therapeutic effect. These ketone bodies serve as alternative energy substrates that normal cells can utilize efficiently while cancer cells cannot, acting as a selective mediator that spares healthy tissue while attacking cancer.
3Reliability
If glucose is restricted to target cancer metabolism, then cancer cell growth is inhibited, but normal cells may also be affected
Solution Approach 1:
The invention applies local quality by providing different metabolic substrates to different cell types. Normal cells receive ketone bodies as an alternative energy source and adapt their metabolism accordingly, while cancer cells with dysfunctional mitochondria cannot utilize ketones and remain dependent on glycolysis. This creates a localized metabolic difference that achieves selectivity.
Solution Approach 2:
The invention employs universality by using ketone bodies as a universal energy substrate that can be utilized by multiple normal cell types across different tissues. Ketone bodies serve as a multi-functional alternative fuel source for the brain, heart, muscle, and other organs, ensuring that normal physiological functions are maintained while cancer cells are targeted.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This combination therapy reduces cancer cell load, limits metastasis, and improves survival time by targeting the abnormal energy metabolism of cancer cells, offering a non-toxic adjuvant treatment that synergistically enhances the efficacy of standard care.
Implementation Method 1
subjecting the animal to a hyperbaric, oxygen-enriched environment
Implementation Method 2
A ketogenic diet supplemented with ketones, combined with hyperbaric oxygen therapy, targets cancer cells by restricting glucose availability
Data Source
Figure 1
Figure 2
Figure 3
AI summary
A method of treating cancer using ketogenic diet, while concurrently subjecting the patient to a hyperbaric, oxygen-enriched environment. Optionally, the hyperbaric, oxygen-enriched environment is 100% oxygen at 2.5 ATA absolute. The treatment may further include administering at least 10% ketone supplementation, such as acetoacetate, adenosine monophosphate kinase, 1,3-butanediol, or ketone ester, to the patient.